Publicaciones en colaboración con investigadores/as de University of California, San Francisco (2)

2015

  1. Recommendations for standardized pathological characterization of residual disease for neoadjuvant clinical trials of breast cancer by the BIG-NABCG collaboration

    Annals of Oncology, Vol. 26, Núm. 7, pp. 1280-1291

2011

  1. A genomic predictor of response and survival following taxane-anthracycline chemotherapy for invasive breast cancer

    JAMA - Journal of the American Medical Association, Vol. 305, Núm. 18, pp. 1873-1881